Transdermal Opioids and the Quality of Life of the Cancer Patient: A Systematic Literature Review
CONCLUSIONS: Transdermal therapy was suggested to have several advantages over oral opioid therapy in enhancing cancer patients' QoL. These benefits span various dimensions, including pain management, physical functioning, mental health, vitality, overall patient improvement, anger/aversion, strength/activity, general QoL, cognitive and emotional functions, fatigue, and insomnia.PMID:38659244 | DOI:10.1177/10600280241247363 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 25, 2024 Category: Drugs & Pharmacology Authors: Patricia Santos Reis Durval Campos Kraychete Emilie de Magalh ães Pedreira Eduardo Silva Reis Barreto C ésar Romero Antunes Júnior Vinicius Borges Alencar Anna Karla do Nascimento Souza Liliane Elze Falc ão Lins-Kusterer Liana Maria Torres de Araujo A Source Type: research
Nirsevimab: Expansion of Respiratory Syncytial Virus Prevention Options in Neonates, Infants, and At-Risk Young Children
CONCLUSIONS: Nirsevimab demonstrated clinical efficacy in reducing RSV-associated MA-LRTI and RSV-associated hospitalizations in infants and was well tolerated.PMID:38654469 | DOI:10.1177/10600280241243357 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 24, 2024 Category: Drugs & Pharmacology Authors: J Hunter Fly Lea S Eiland Jeremy S Stultz Source Type: research
Daprodustat: A Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia of Chronic Kidney Disease
CONCLUSIONS: Daprodustat is a novel oral, non-iron therapy for treatment of anemia of CKD. It was Food and Drug Administration approved in 2023 in patients already receiving dialysis for at least 4 months but not in non-dialysis patients. Long-term data for safety and additional benefits are pending.PMID:38616529 | DOI:10.1177/10600280241241563 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Haley N Johnson Lalita Prasad-Reddy Source Type: research
Abbreviated Urine Collection Compared With 24-Hour Urine Collection for Measuring Creatinine Clearance in Adult Critically Ill Patients: A Systematic Review
CONCLUSIONS: Abbreviated urine collection may overestimate CrCl compared with 24-hour urine collection. Larger, well-conducted studies are needed to evaluate the accuracy of CrCl measured using different durations of urine collection in critically ill patients.PMID:38619016 | DOI:10.1177/10600280241241820 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Mohamed Omar Saad Adham Mohamed Mohamed Izham Mohamed Ibrahim Source Type: research
Daprodustat: A Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia of Chronic Kidney Disease
CONCLUSIONS: Daprodustat is a novel oral, non-iron therapy for treatment of anemia of CKD. It was Food and Drug Administration approved in 2023 in patients already receiving dialysis for at least 4 months but not in non-dialysis patients. Long-term data for safety and additional benefits are pending.PMID:38616529 | DOI:10.1177/10600280241241563 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Haley N Johnson Lalita Prasad-Reddy Source Type: research
Abbreviated Urine Collection Compared With 24-Hour Urine Collection for Measuring Creatinine Clearance in Adult Critically Ill Patients: A Systematic Review
CONCLUSIONS: Abbreviated urine collection may overestimate CrCl compared with 24-hour urine collection. Larger, well-conducted studies are needed to evaluate the accuracy of CrCl measured using different durations of urine collection in critically ill patients.PMID:38619016 | DOI:10.1177/10600280241241820 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Mohamed Omar Saad Adham Mohamed Mohamed Izham Mohamed Ibrahim Source Type: research
Daprodustat: A Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia of Chronic Kidney Disease
CONCLUSIONS: Daprodustat is a novel oral, non-iron therapy for treatment of anemia of CKD. It was Food and Drug Administration approved in 2023 in patients already receiving dialysis for at least 4 months but not in non-dialysis patients. Long-term data for safety and additional benefits are pending.PMID:38616529 | DOI:10.1177/10600280241241563 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Haley N Johnson Lalita Prasad-Reddy Source Type: research
Abbreviated Urine Collection Compared With 24-Hour Urine Collection for Measuring Creatinine Clearance in Adult Critically Ill Patients: A Systematic Review
CONCLUSIONS: Abbreviated urine collection may overestimate CrCl compared with 24-hour urine collection. Larger, well-conducted studies are needed to evaluate the accuracy of CrCl measured using different durations of urine collection in critically ill patients.PMID:38619016 | DOI:10.1177/10600280241241820 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Mohamed Omar Saad Adham Mohamed Mohamed Izham Mohamed Ibrahim Source Type: research
Daprodustat: A Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia of Chronic Kidney Disease
CONCLUSIONS: Daprodustat is a novel oral, non-iron therapy for treatment of anemia of CKD. It was Food and Drug Administration approved in 2023 in patients already receiving dialysis for at least 4 months but not in non-dialysis patients. Long-term data for safety and additional benefits are pending.PMID:38616529 | DOI:10.1177/10600280241241563 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Haley N Johnson Lalita Prasad-Reddy Source Type: research
Abbreviated Urine Collection Compared With 24-Hour Urine Collection for Measuring Creatinine Clearance in Adult Critically Ill Patients: A Systematic Review
CONCLUSIONS: Abbreviated urine collection may overestimate CrCl compared with 24-hour urine collection. Larger, well-conducted studies are needed to evaluate the accuracy of CrCl measured using different durations of urine collection in critically ill patients.PMID:38619016 | DOI:10.1177/10600280241241820 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Mohamed Omar Saad Adham Mohamed Mohamed Izham Mohamed Ibrahim Source Type: research
Amiodarone-Induced Psoriasiform Dermatitis
Ann Pharmacother. 2024 Apr 8:10600280241244511. doi: 10.1177/10600280241244511. Online ahead of print.NO ABSTRACTPMID:38590149 | DOI:10.1177/10600280241244511 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 9, 2024 Category: Drugs & Pharmacology Authors: Myriam Agrebi Dhouha Sahnoun Najet Ghariani Mohamed Denguezli Chaker Ben Salem Source Type: research
Amiodarone-Induced Psoriasiform Dermatitis
Ann Pharmacother. 2024 Apr 8:10600280241244511. doi: 10.1177/10600280241244511. Online ahead of print.NO ABSTRACTPMID:38590149 | DOI:10.1177/10600280241244511 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 9, 2024 Category: Drugs & Pharmacology Authors: Myriam Agrebi Dhouha Sahnoun Najet Ghariani Mohamed Denguezli Chaker Ben Salem Source Type: research
Amiodarone-Induced Psoriasiform Dermatitis
Ann Pharmacother. 2024 Apr 8:10600280241244511. doi: 10.1177/10600280241244511. Online ahead of print.NO ABSTRACTPMID:38590149 | DOI:10.1177/10600280241244511 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 9, 2024 Category: Drugs & Pharmacology Authors: Myriam Agrebi Dhouha Sahnoun Najet Ghariani Mohamed Denguezli Chaker Ben Salem Source Type: research
Amiodarone-Induced Psoriasiform Dermatitis
Ann Pharmacother. 2024 Apr 8:10600280241244511. doi: 10.1177/10600280241244511. Online ahead of print.NO ABSTRACTPMID:38590149 | DOI:10.1177/10600280241244511 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 9, 2024 Category: Drugs & Pharmacology Authors: Myriam Agrebi Dhouha Sahnoun Najet Ghariani Mohamed Denguezli Chaker Ben Salem Source Type: research
Amiodarone-Induced Psoriasiform Dermatitis
Ann Pharmacother. 2024 Apr 8:10600280241244511. doi: 10.1177/10600280241244511. Online ahead of print.NO ABSTRACTPMID:38590149 | DOI:10.1177/10600280241244511 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 9, 2024 Category: Drugs & Pharmacology Authors: Myriam Agrebi Dhouha Sahnoun Najet Ghariani Mohamed Denguezli Chaker Ben Salem Source Type: research
